Daniel Rowland Cowell
Directeur Général chez Medeor Old Ltd.
Profil
Daniel Rowland Cowell is the founder of Sigma Entity One Ltd.
founded in 2003.
He is currently the Chief Executive Officer & Director at Medeor Old Ltd., a Director at Sentinel Oncology Ltd., and a Director at techspert.io Ltd.
Mr. Cowell's former positions include Director & Vice President-Operations at Horizon Discovery Ltd.
in 2013, and Principal positions at Millennium Pharmaceuticals, Inc., Cambridge Combinatorial Ltd., Cambridge Material Science, Inc., and Oxford Diversity, Inc. Mr. Cowell is also the founder of Hypoxium Ltd.
Postes actifs de Daniel Rowland Cowell
| Sociétés | Poste | Début |
|---|---|---|
Sentinel Oncology Ltd.
 Sentinel Oncology Ltd. BiotechnologyHealth Technology Sentinel Oncology Ltd. operates as a molecule drug discovery company. The firm develops and commercializes new therapeutics to treat cancer where there is an unmet medical need. The company was founded by Stuart Travers, Robert G. Boyle, Ashok Venkitaraman and Gavin Simpson in 2005 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | - |
Medeor Old Ltd.
 Medeor Old Ltd. Miscellaneous Commercial ServicesCommercial Services Medeor Old Ltd. provides business support services. The company is headquartered in Cambridge, the United Kingdom. | Directeur Général | - |
techspert.io Ltd.
 techspert.io Ltd. Packaged SoftwareTechnology Services techspert.io Ltd. develops and provides artificial intelligence solutions for marketing products. The firm offers techspert.io platform. The company was founded by David Holden-White and Graham Mills on November 16, 2015 and is headquartered in Cambridge, the United Kingdom. | Directeur/Membre du Conseil | 15/07/2016 |
Anciens postes connus de Daniel Rowland Cowell
| Sociétés | Poste | Fin |
|---|---|---|
Sigma Entity One Ltd.
 Sigma Entity One Ltd. Miscellaneous Commercial ServicesCommercial Services Sigma Entity One Ltd. provides solid-form research services to the pharmaceutical and biotech markets. The company was founded by David Tapolczay and Daniel Rowland Cowell on July 16, 2003 and is headquartered in Gillingham, the United Kingdom. | Fondateur | - |
| Hypoxium Ltd. | Fondateur | - |
| Oxford Diversity, Inc. | Corporate Officer/Principal | - |
| Cambridge Material Science, Inc. | Corporate Officer/Principal | - |
Cambridge Combinatorial Ltd.
 Cambridge Combinatorial Ltd. Industrial ConglomeratesProducer Manufacturing Part of Dassault Systèmes SA, Cambridge Combinatorial Ltd. is a company engaged in the design, production and supply of compounds for the pharmaceutical industry. The company is based in Cambridge, UK. Cambridge Combinatorial was acquired by Oxford Molecular Group Plc on October 15, 1998 for $20.78 million. The British company was founded by Allan P. Marchington. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 10 |
|---|---|
Horizon Discovery Ltd.
 Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Horizon Discovery Ltd. develops and supplying patient-relevant drug discovery and diagnostic research tools. The frm also supplies genetically-defined cell lines, reporter gene assay kits, genomic reference standards and contract research services to organizations engaged in bio-pharmaceutical process optimization, drug discovery & development, and clinical diagnostic development. The company was founded by Christopher John Torrance and Alberto Bardelli on February 14, 2005 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Health Technology |
Cambridge Combinatorial Ltd.
Cambridge Combinatorial Ltd. Industrial ConglomeratesProducer Manufacturing Part of Dassault Systèmes SA, Cambridge Combinatorial Ltd. is a company engaged in the design, production and supply of compounds for the pharmaceutical industry. The company is based in Cambridge, UK. Cambridge Combinatorial was acquired by Oxford Molecular Group Plc on October 15, 1998 for $20.78 million. The British company was founded by Allan P. Marchington. | Producer Manufacturing |
| Cambridge Material Science, Inc. | |
| Oxford Diversity, Inc. | |
Sigma Entity One Ltd.
Sigma Entity One Ltd. Miscellaneous Commercial ServicesCommercial Services Sigma Entity One Ltd. provides solid-form research services to the pharmaceutical and biotech markets. The company was founded by David Tapolczay and Daniel Rowland Cowell on July 16, 2003 and is headquartered in Gillingham, the United Kingdom. | Commercial Services |
| Hypoxium Ltd. | Commercial Services |
Sentinel Oncology Ltd.
Sentinel Oncology Ltd. BiotechnologyHealth Technology Sentinel Oncology Ltd. operates as a molecule drug discovery company. The firm develops and commercializes new therapeutics to treat cancer where there is an unmet medical need. The company was founded by Stuart Travers, Robert G. Boyle, Ashok Venkitaraman and Gavin Simpson in 2005 and is headquartered in Cambridge, the United Kingdom. | Health Technology |
Medeor Old Ltd.
Medeor Old Ltd. Miscellaneous Commercial ServicesCommercial Services Medeor Old Ltd. provides business support services. The company is headquartered in Cambridge, the United Kingdom. | Commercial Services |
techspert.io Ltd.
techspert.io Ltd. Packaged SoftwareTechnology Services techspert.io Ltd. develops and provides artificial intelligence solutions for marketing products. The firm offers techspert.io platform. The company was founded by David Holden-White and Graham Mills on November 16, 2015 and is headquartered in Cambridge, the United Kingdom. | Technology Services |
